Honestly a big reason Nader had to go was because
Post# of 144517
![](/assets/46931549/no_avatar_available_thumb.jpg)
Thankfully the separation has been made and with Tanya Durkee Urbach on the Board, I am confident that public statements going forward will comport with what's expected from regulators. Adding a more professional culture to a potential blockbuster drug is a winning formula going forward.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)